Compugen Says Q2 Revenue Declines 92 Percent as Loss Grows 9 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Compugen today said that total revenues for the three months ended June 30 decreased more than 92 percent to $5,000 from $70,000.
Compugen reported a 74-percent decline in government grants to $105,000, from $404,000 year over year. Compugen said total revenues were “as anticipated.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.